ESENBOĞA, K. Et Al. 2022. Evaluation of the Impact of Ranolazine Treatment on Liver Function Tests in Patients With Coronary Heart Disease and Nonalcoholic Fatty Liver Disease. Angiology , vol.73, no.1 , 73-78.

ESENBOĞA, K., KURTUL, A., Nazman, H., Tekin, C. G., ÖZYÜNCÜ, N., Tan, T. S., ... Tutar, E.(2022). Evaluation of the Impact of Ranolazine Treatment on Liver Function Tests in Patients With Coronary Heart Disease and Nonalcoholic Fatty Liver Disease. Angiology , vol.73, no.1, 73-78.

ESENBOĞA, KERİM Et Al. "Evaluation of the Impact of Ranolazine Treatment on Liver Function Tests in Patients With Coronary Heart Disease and Nonalcoholic Fatty Liver Disease," Angiology , vol.73, no.1, 73-78, 2022

ESENBOĞA, KERİM Et Al. "Evaluation of the Impact of Ranolazine Treatment on Liver Function Tests in Patients With Coronary Heart Disease and Nonalcoholic Fatty Liver Disease." Angiology , vol.73, no.1, pp.73-78, 2022

ESENBOĞA, K. Et Al. (2022) . "Evaluation of the Impact of Ranolazine Treatment on Liver Function Tests in Patients With Coronary Heart Disease and Nonalcoholic Fatty Liver Disease." Angiology , vol.73, no.1, pp.73-78.

@article{article, author={KERİM ESENBOĞA Et Al. }, title={Evaluation of the Impact of Ranolazine Treatment on Liver Function Tests in Patients With Coronary Heart Disease and Nonalcoholic Fatty Liver Disease}, journal={Angiology}, year=2022, pages={73-78} }